Punyawattanaporn Achara, Tengtrisorn Supaporn, Sangsupawanich Pasuree
Department of Ophthalmology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
J Med Assoc Thai. 2009 Nov;92(11):1458-62.
To compare the pupillary response to a single drop and three drops of a combination of eye drops (0.2% cyclopentolate and 1.0% phenylephrine) in preterm infants.
Prospective comparative study.
Preterm infants scheduled to undergo their first retinopathy of prematurity (ROP) screening in the Neonatal Intensive Care Unit, Songklanagarind Hospital, between 1 August 2007 and 30 August 2008, were enrolled in the present study. An eyelid speculum was placed after the topical anesthetic, 0.5% tetracaine, application to measure the baseline horizontal pupil diameter with a Vernier caliper. Then each eye was randomized to either receive a drop of mixture of 0.2% cyclopentolate and 1.0% phenylephrine single dose for group A, or triple doses of 10-minute interval for group B. The pupil diameter was measured at 45 and 60 minutes after instillation and a fundus examination was performed afterward.
Seventy preterm infants, 45 males and 25 females, were included in the present study. The mean gestational age was 30.49 +/- 2.34 weeks (range of 24-36 weeks) and the mean birth weight was 1,368.00 +/- 438.99 grams (range of 640-2,850 grams). At baseline, the mean pupil diameter was 2.18 +/- 0.44 mm in group A and 2.19 +/- 0.44 mm in group B (p = 0.90). The mean pupil diameter at 45 minutes after instillation was 5.50 +/- 0.80 mm in group A and 6.02 +/- 0.56 mm in group B (p < 0.01). At 60 minutes after instillation, the mean pupil diameter was 6.13 +/- 0.82 mm in group A and 6.77 +/- 0.41 mm in group B (p < 0.01).
The pupil size of preterm infants was significantly larger after three drops of the eye drop mixture (0.2% cyclopentolate and 1.0% phenylephrine) than after a single drop. However, a dilated pupil diameter > or = 6 mm was adequate for the peripheral retina examination.
比较早产儿对一滴和三滴眼药水组合(0.2%环喷托酯和1.0%去氧肾上腺素)的瞳孔反应。
前瞻性对照研究。
纳入2007年8月1日至2008年8月30日期间在宋卡纳加拉林医院新生儿重症监护病房计划进行首次早产儿视网膜病变(ROP)筛查的早产儿。在应用0.5%丁卡因局部麻醉后放置眼睑撑开器,用游标卡尺测量基线水平瞳孔直径。然后将每只眼睛随机分为A组,接受一滴0.2%环喷托酯和1.0%去氧肾上腺素混合液单剂量滴眼;或B组,接受三剂,间隔10分钟滴眼。滴眼后45分钟和60分钟测量瞳孔直径,之后进行眼底检查。
本研究纳入70例早产儿,男45例,女25例。平均胎龄为30.49±2.34周(范围24 - 36周),平均出生体重为1368.00±438.99克(范围640 - 2850克)。基线时,A组平均瞳孔直径为2.18±0.44毫米,B组为2.19±0.44毫米(p = 0.90)。滴眼后45分钟,A组平均瞳孔直径为5.50±0.80毫米,B组为6.02±0.56毫米(p < 0.01)。滴眼后60分钟,A组平均瞳孔直径为6.13±0.82毫米,B组为6.77±0.41毫米(p < 0.01)。
早产儿滴眼三滴眼药水组合(0.2%环喷托酯和1.0%去氧肾上腺素)后的瞳孔大小明显大于滴一滴后的瞳孔大小。然而,瞳孔直径扩张至≥6毫米足以进行周边视网膜检查。